Patient Buzz Series: Sharpie Lip-Liner Trend
Using a Sharpie as a lip liner is the latest TikTok trend raising concerns among dermatologists. Some social media influencers say using a permanent marker is a cheaper alternative to traditional lip liner. However, an article by Fox News quotes the Northern New England Poison Center’s website, which says the ink in permanent markers may contain xylene, toluene, and urethane resin. Dermatologist …
Using a Sharpie as a lip liner is the latest TikTok trend raising concerns among dermatologists. Some social media influencers say using a permanent marker is a cheaper alternative to traditional lip liner. However, an article by Fox News quotes the Northern New England Poison Center’s website, which says the ink in permanent markers may contain xylene, toluene, and urethane resin. Dermatologist … Continue reading "Patient Buzz Series: Sharpie Lip-Liner Trend"
Dermatologists play a crucial role in the care of patients with sexually transmitted diseases (STDs), as many STDs manifest on the skin. At the 2024 Skin of Color Update, Dr. Theodore Rosen, Professor of Dermatology at Baylor College of Medicine, shared valuable insights on diagnosing and managing STDs in patients with skin of color. This article reviews the prevalence of STDs, their distinctive p … 
New developments in neurotoxins may lead to additional applications and improved safety, according to Dr. Terrence Keaney, associate clinical professor of dermatology at GW School of Medicine & Health Sciences. Next Steps in Derm, in partnership with ODAC Dermatology Conference, interviewed Dr. Keaney, who shared how a new botulinum toxin subtype may serve as a “tester toxin” for curious, … 
At the most recent Skin of Color Update, we had the honor to learn about pediatric inflammatory skin conditions from the renowned Dr. Candrice Heath, triple board-certified dermatologist and Associate Professor at the Howard University Department of Dermatology and Dr. Brandi Kenner-Bell, Assistant Professor of Dermatology and Pediatrics at the Northwestern University Feinberg School of Medicine.
… 
Secukinumab is a recombinant human monoclonal immunoglobulin IgG1κ antibody that selectively targets interleukin-17A (IL-17A), a key effector cytokine in the Th17 pathway implicated in the pathogenesis of psoriasis. With its high target specificity, rapid onset, sustained efficacy, and favorable safety profile, secukinumab has become a mainstay in the treatment of psoriasis and other inflammatory …